OsteoBalance

by Pure Encapsulations

*OsteoBalance™ provides 1,200 mg of calcium per serving from calcium citrate/malate and calcium microcrystalline hydoxyapatite (MCHA). This formula also includes a comprehensive profile of important bone building nutrients. Calcium citrate/malate has excellent bioavailability and provided bone mass support for postmenopausal women with low dietary calcium intake in a two-year, double-blind placebo-controlled trial. In a separate two-year trial, calcium MCHA maintained healthy bone mineral content in volunteers. One study demonstrated that concomitant supplementation of the trace minerals zinc, copper, and manganese with calcium citrate/malate helped to promote proper bone metabolism in postmenopausal subjects. Magnesium supports healthy bone mineral density and boron plays an important role in reducing urinary calcium and magnesium excretion. Like boron, vitamin D reduces urinary calcium loss but is also a key nutrient because it enhances calcium absorption.

OsteoBalance™ provides a high calcium osteoporosis support formula with additional nutritional factors that promote optimal calcium absorption and retention and enhance healthy bone mineralization.

REFERENCE: Ricci TA, Chowdhury HA, Heymsfield SB, Stahl T, Pierson RN Jr, Shapses SA. Calcium supplementation suppresses bone turnover during weight reduction in postmenopausal women. J Bone Miner Res 1998 Jun;13(6):1045-50.

†Risk factors for osteoporosis include sex, race, age and inadequate calcium intake. Populations at highest risk for osteoporosis include Caucasian, Asian, and postmenopausal women, and elderly women and men. Adequate calcium intake throughout life is linked to a reduced risk of osteoporosis, as calcium helps to optimize peak bone mass during adolescence and early adulthood in conjunction with exercise and healthy diet. Calcium intake greater than 2,000 mg per day has no further known benefit to bone health.